Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Ming-Chu Hsue

TaiGen Biotechnology Co. Ltd., Taipei, Taiwan

Biography

Dr. Ming-Chu Hsue is currently working in TaiGen Biotechnology Co. Ltd., Taipei, Taiwan. Dr. Ming-Chu Hsue has authored of many research articles  related to Medicine. Dr. Ming-Chu Hsue is serving as an editorial member and reviewer of several international reputed journals. Dr. Ming-Chu Hsue has successfully completed Administrative responsibilities. Dr. Ming-Chu Hsue research interests includes Medicine.
Publications

A Pilot Study of Nemonoxacin in Patients with Diabetic Foot Infections

Background: Diabetic foot infections (DFIs) are usually caused by a mixture of bacterial pathogens, especially staphylococci (including methicillin-resistant strains). Nemonoxacin, a broad-spectrum non-fluorinated quinolone with activity against methicillin-resistant Staphylococcus aureus (MRSA), could potentially be an effective agent to treat DFI... Read More»

Benjamin A Lipsky, Mashra Ganib, Lee C Rogers, Jawl-Shan Hwang, Cheng-Yuan Tsaie, Li-Wen Chang, Yu-Ting Chang and Ming-Chu Hsue

: J Infect Dis Ther 2019, 4:397

10.4172/2332-0877.1000397

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top